1 min read
Add as a preferred source on Google

Novartis Sets 5% Annual Net Sales Growth Target Through 2031

The foreign exchange-adjusted target covers 2026 to 2031. Novartis shares fell in Zurich after the company updated its midterm outlook.

A glass ampoule beside a rising etched line on a laboratory panel / TokenPost.ai
A glass ampoule beside a rising etched line on a laboratory panel / TokenPost.ai

Novartis set a foreign exchange-adjusted target for net sales to grow at a 5% compound annual rate from 2026 through 2031, while its shares fell in Zurich after the Swiss drugmaker updated its midterm outlook on Nov. 19.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…